ID

23898

Descripción

Study part: Non- Serious Adverse Events. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Palabras clave

Versiones (1)
  1. 17/7/17 17/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

17 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Non- Serious Adverse Events Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Inglés

Non- Serious Adverse Events

1 formularios  
NON-SERIOUS ADVERSE EVENTS
Descripción

NON-SERIOUS ADVERSE EVENTS

Alias
UMLS CUI-1
C1518404
Subject number
Descripción

Subject number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Descripción

non-serious adverse events

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518404
Description
Descripción

Description Non- Serious Adverse Events

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Administration sites
Descripción

site vaccines

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Non-administration site
Descripción

site vaccines

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started
Descripción

Date Started

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
Date Started-during immediate post-vaccination period (at least 30 minutes)
Descripción

Date Started

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0808070
Date Stopped
Descripción

Date Stopped

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
Intensity
Descripción

Intensity

Tipo de datos

text

Alias
UMLS CUI [1]
C1710066
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descripción

adverse event drug study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome
Descripción

Outcome

Tipo de datos

integer

Alias
UMLS CUI [1]
C1705586
Did the subject seek medical advice?
Descripción

medical advice

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1386497
If yes please specify type:
Descripción

medical advice

Tipo de datos

integer

Alias
UMLS CUI [1]
C1386497
Volver a la parte superior de la página

Similar models

Non- Serious Adverse Events

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
NON-SERIOUS ADVERSE EVENTS
C1518404 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
non-serious adverse events
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
Description Non- Serious Adverse Events
Item
Description
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Administration sites
integer
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
site vaccines
Code List
Administration sites
CL Item
Hib-MenCY OR Hib-MenC vaccine [ 9 0 1 ] (1)
CL Item
MenC vaccine [ 9 0 2 ] (2)
CL Item
DTPa-HBV-IPV vaccine [ 1 4 ] (3)
CL Item
DTPa-HBV-IPV/Hib vaccine [ 3 8 ] (4)
site vaccines
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started
Item
Date Started
date
C0808070 (UMLS CUI [1])
Date Started
Item
Date Started-during immediate post-vaccination period (at least 30 minutes)
boolean
C0808070 (UMLS CUI [1])
Date Stopped
Item
Date Stopped
date
C0806020 (UMLS CUI [1])
Item
Intensity
text
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
adverse event drug study
Item
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered / Resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae /Resolved with sequelae (4)
medical advice
Item
Did the subject seek medical advice?
boolean
C1386497 (UMLS CUI [1])
Item
If yes please specify type:
integer
C1386497 (UMLS CUI [1])
medical advice
Code List
If yes please specify type:
CL Item
HO: Hospitalisation (1)
CL Item
ER: Emergency room (2)
CL Item
MD: Medical doctor (3)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial